BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25186179)

  • 1. The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation.
    Weber DJ; Gracon AS; Ripsch MS; Fisher AJ; Cheon BM; Pandya PH; Vittal R; Capitano ML; Kim Y; Allette YM; Riley AA; McCarthy BP; Territo PR; Hutchins GD; Broxmeyer HE; Sandusky GE; White FA; Wilkes DS
    Sci Transl Med; 2014 Sep; 6(252):252ra124. PubMed ID: 25186179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction.
    Weber DJ; Allette YM; Wilkes DS; White FA
    Antioxid Redox Signal; 2015 Dec; 23(17):1316-28. PubMed ID: 25751601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the receptor for advanced glycation end-products in lung fibrosis.
    He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
    Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.
    Sachdev U; Cui X; Tzeng E
    J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia.
    Achouiti A; van der Meer AJ; Florquin S; Yang H; Tracey KJ; van 't Veer C; de Vos AF; van der Poll T
    Crit Care; 2013 Dec; 17(6):R296. PubMed ID: 24342460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain injury requires lung protection.
    Lopez-Aguilar J; Blanch L
    Ann Transl Med; 2015 May; 3(Suppl 1):S5. PubMed ID: 26046092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
    Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
    J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
    Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
    J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury.
    Gao TL; Yuan XT; Yang D; Dai HL; Wang WJ; Peng X; Shao HJ; Jin ZF; Fu ZJ
    J Trauma Acute Care Surg; 2012 Mar; 72(3):643-9. PubMed ID: 22491548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.
    Sharma AK; LaPar DJ; Stone ML; Zhao Y; Kron IL; Laubach VE
    Am J Transplant; 2013 Sep; 13(9):2255-67. PubMed ID: 23865790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
    Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine Protects Against Traumatic Brain Injury-Induced Acute Lung Injury in Mice.
    Wang Y; Wang C; Zhang D; Wang H; Bo L; Deng X
    Med Sci Monit; 2018 Jul; 24():4961-4967. PubMed ID: 30013022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation.
    Hiraku Y; Guo F; Ma N; Yamada T; Wang S; Kawanishi S; Murata M
    Part Fibre Toxicol; 2016 Mar; 13():16. PubMed ID: 27026438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traumatic brain injury: lungs in a RAGE.
    Nicolls MR; Laubach VE
    Sci Transl Med; 2014 Sep; 6(252):252fs34. PubMed ID: 25186173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of dexmedetomidine in cecal ligation perforation-induced acute lung injury through HMGB1/RAGE pathway regulation and pyroptosis activation.
    Sun H; Hu H; Xu X; Fang M; Tao T; Liang Z
    Bioengineered; 2021 Dec; 12(2):10608-10623. PubMed ID: 34747306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of high mobility group box-1 protein on cerebral edema, blood-brain barrier, oxidative stress and apoptosis in an experimental traumatic brain injury model.
    Evran S; Calis F; Akkaya E; Baran O; Cevik S; Katar S; Gurevin EG; Hanimoglu H; Hatiboglu MA; Armutak EI; Karatas E; Kocyigit A; Kaynar MY
    Brain Res Bull; 2020 Jan; 154():68-80. PubMed ID: 31715313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion.
    Dvoriantchikova G; Hernandez E; Grant J; Santos AR; Yang H; Ivanov D
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7187-94. PubMed ID: 21828158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
    Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HMGB1 receptor RAGE mediates ischemic brain damage.
    Muhammad S; Barakat W; Stoyanov S; Murikinati S; Yang H; Tracey KJ; Bendszus M; Rossetti G; Nawroth PP; Bierhaus A; Schwaninger M
    J Neurosci; 2008 Nov; 28(46):12023-12031. PubMed ID: 19005067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
    Okuma Y; Liu K; Wake H; Zhang J; Maruo T; Date I; Yoshino T; Ohtsuka A; Otani N; Tomura S; Shima K; Yamamoto Y; Yamamoto H; Takahashi HK; Mori S; Nishibori M
    Ann Neurol; 2012 Sep; 72(3):373-84. PubMed ID: 22915134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.